What Rosalind Advisors, Inc. reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1622627 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 3.2M |
| +9.6% |
| $34.3M |
| 12.7% |
XERSXeris Biopharma Holdings, Inc. | 2.9M | −10.0% | $23M | 8.6% |
SVRASavara Inc | 3.2M | −0.8% | $19.6M | 7.3% |
VSTMVerastem, Inc. | 4M | +86.4% | $15.2M | 5.7% |
XFORX4 Pharmaceuticals, Inc | 3.2M | ±0% | $15M | 5.6% |
EYPTEyePoint, Inc. | 988.2K | −4.7% | $14.1M | 5.2% |
HELPHelus Pharma Inc. | 2M | +27.7% | $12.9M | 4.8% |
VORVor Biopharma Inc. | 648.6K | −7.3% | $11.9M | 4.4% |
PCVXVaxcyte, Inc. | 200K | −31.0% | $11.6M | 4.3% |
MDWDMediWound Ltd. | 749.1K | ±0% | $11M | 4.1% |
CLDXCelldex Therapeutics, Inc. | 200K | −39.4% | $7.4M | 2.8% |
BCRXBiocryst Pharmaceuticals Inc | 721.5K | −21.8% | $7.2M | 2.7% |
PROFProfound Medical Corp. | 828.1K | ±0% | $5.5M | 2% |
TLPHTalphera, Inc. | 5.2M | +54.1% | $5.3M | 2% |
AVIRAtea Pharmaceuticals, Inc. | 1.1M | −8.6% | $5M | 1.8% |
MYOMyomo, Inc. | 3.6M | −5.4% | $3.8M | 1.4% |
OVIDOvid Therapeutics Inc. | 1.1M | ±0% | $3M | 1.1% |
NRXSNeuraxis, INC | 508.1K | +77.6% | $3M | 1.1% |
ABVXAbivax S.A. | 20.9K | New | $2.8M | 1% |
NSPRInspireMD, Inc. | 3.9M | ±0% | $2.7M | 1% |
RGNTRegentis Biomaterials Ltd. | 701.7K | +179.0% | $2.5M | 0.9% |
SELLAS LIFE SCIENCES GROUP INCPUTPut option | 568.7K | New | $2.3M | 0.9% |
PYPDPolyPid Ltd. | 389.5K | −34.9% | $2M | 0.7% |
BFRIBiofrontera Inc. | 1.3M | +9.6% | $1.2M | 0.4% |
KURAKura Oncology, Inc. | 100K | ±0% | $1.1M | 0.4% |
SPRBSpruce Biosciences, Inc. | 20K | New | $1.1M | 0.4% |
AQSTAquestive Therapeutics, Inc. | 250K | ±0% | $1M | 0.4% |
OKUROnKure Therapeutics, Inc. | 150K | −66.2% | $684K | 0.3% |
PEPGPepGen Inc. | 350K | New | $630K | 0.2% |
CG ONCOLOGY INCCALLCall option | 31K | New | $375.1K | 0.1% |
EYEPOINT PHARMACEUTICALS INCCALLCall option | 50.3K | New | $130.8K | 0.1% |
ISHARES TRPUTPut option | 500K | New | $110K | 0.1% |
SPDR SERIES TRUSTPUTPut option | 140.6K | New | $35.2K | 0.1% |
TENAX THERAPEUTICS INCPUTPut option | 6.2K | New | $14K | 0.1% |
